A Dutch company has marketed its brand of a highly effective anti-snoring throat spray for nearly one decade in several European markets and more recently in Canada and Australia.
The efficacy and safety of this medical device class 2A has been clinically documented and approved by the notified body.
The spray significantly diminishes and eliminates snoring and the majority of users and their partners claim to wake up well rested.
The company is currently looking to expand its sales to new markets in Europe, especially the Nordic countries, Germany, Austria, Switzerland and France. Therefore it is looking for distributors of Over The Counter (OTC) products to pharmacies or drugstores to cooperate in the frame of a distribution services agreement or a license agreement
Advantages & innovations
The product has unique features based on the combination of a formula with astringent properties and an easy to use, state of the art, ergonomic delivery system.
- herbal astringent components form a thin layer in the throat that counters the vibrations and also the rumbling sound.
- one spray, targeted directly on the right spot, so very easy to use just before going to sleep. - bag on valve system, so no contact between fluid and propellant. - registered as medical device class 2A, so sufficient clinical documentation to make credible sales
Stage of development
Already on the market
Partner sought
Marketing and distribution company interested in buying and taking stock and taking full responsibility for distribution of the medical device to pharmacy/drugstores.
In case of a license agreement the partner would perform these activities under their brand name.